A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...

A patient has achieved over 18 years of remission from neuroblastoma, a type of nerve cell cancer, following treatment with ...

Hearing that your child has neuroblastoma can be frightening and overwhelming. It can be daunting to think about the treatments your child may need and how the experience will affect your child, your ...

A fundraiser to help with life-saving cancer treatment for a five-year-old girl has exceeded €300,000 in just ten days of ...

Stephanie Kent’s daughter Flora was just two years old when she was diagnosed with Neuroblastoma - a devastating childhood ...

CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.

Neuroblastoma is the most common extracranial solid tumor in children, with nearly 50% of cases diagnosed at an advanced stage, often with metastatic disease. Despite advances in treatment ...

International Childhood Cancer Day aims to spread awareness about childhood cancers. Childhood cancers (0-14 years of age) ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...